NASHVILLE, TN. (April 1, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased to announce...
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
NASHVILLE, TN. (February 5, 2024) – Nearly 107,000 Americans died from a drug overdose in 2021, according to the Centers for Disease...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill),...
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Sign up for the Aegis Newsletter